A Broadleaf article.
This case describes how an international pharmaceutical company used risk management to examine a significant long-term strategic agreement with another organisation in a complementary medical sector, for the purpose of developing improvement actions to enhance its success.
The case discusses how the process was planned and conducted, and how the company’s enterprise risk management processes were tailored for the specific strategic and implementation decisions that were involved. It also discusses how the company made sense of the large amount of information generated in a series of risk-related workshops, to develop a practical and manageable set of improvement plans.
Read the full case here.